Tc17 Cells in Immunity and Systemic Autoimmunity

Tc17 cells-a subset of CD8+T cells-have recently been identified that are characterized by the production of interleukin (IL)-17. Cytokines IL-6 and transforming growth factor-beta 1 (TGF-β1) and transcription factors signaling transducers and activators of transcription (STAT)3, retinoic acid receptor-related orphan nuclear receptor gamma (RORγt), and interferon regulatory factor (IRF)4 are necessary for differentiation of Tc17 cells, controlling expression of molecules essential for Tc17 cell trafficking and function. Current human researches have determined the significance of CD161 expression as either a marker of Tc17 cells or as an effector and regulator of Tc17 cell function. Noncytotoxic Tc17 cells possess a high plasticity to convert into IFN-γ producing cells, which exhibit strong cytotoxic activity. The importance of in vivo plasticity of Tc17 cells for the induction of autoimmune diseases has been demonstrated and Tc17 cells potentially represent novel therapeutic targets in autoimmune diseases. The involvement of interleukin (IL)-17-producing CD8+T cells (Tc17) in various conditions, such as infection, cancer, and autoimmune inflammation, has been documented in both humans and mice; however, Tc17 cells have received only marginal attention. Here, we provide an overview of the cytokines and chemokines that characterize the murine and human Tc17 cells. Moreover, we discuss signaling pathways, molecular interactions, and transcriptional events that contribute to Tc17 differentiation and acquisition of effector functions. Also considered is the basis of Tc17 cell plasticity toward the Tc1 lineage, and we suggest that in vivo plasticity of Tc17 cells may be a key feature of Tc17 cell biology in autoimmune diseases. Furthermore, current human researches have revealed that Tc17 cells are different than that in mice because all of them express CD161 and exclusively originate from CD161 precursors present in umbilical cord blood. Finally, we focus on the recent evidence for long-lived Tc17 memory cell populations in mouse models and humans, and their functional roles in mediating disease memory. Hopefully, the information obtained will benefit for developing novel therapeutic strategies.

[1]  K. Tedford,et al.  CTLA‐4 (CD152) enhances the Tc17 differentiation program , 2014, European journal of immunology.

[2]  P. Miossec,et al.  Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. , 2014, Autoimmunity reviews.

[3]  R. Nussenblatt,et al.  Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). , 2014, Clinical immunology.

[4]  B. Kirkham,et al.  Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression , 2014, Arthritis & rheumatology.

[5]  M. Ståhle,et al.  Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis , 2014, The Journal of Immunology.

[6]  Mark S. Sundrud,et al.  Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo , 2014, The Journal of Immunology.

[7]  Yan Zhang,et al.  Tc17 Cells in Patients with Uterine Cervical Cancer , 2014, PloS one.

[8]  Tao Yang,et al.  Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes , 2014, Endocrine.

[9]  Björn Rúnar Lúðvíksson,et al.  The Role of Th17/Tc17 Peripheral Blood T cells in Psoriasis and Their Positive Therapeutic Response , 2013, Scandinavian journal of immunology.

[10]  C. Streutker,et al.  Constitutive induction of intestinal Tc17 cells in the absence of hematopoietic cell‐specific MHC class II expression , 2013, European journal of immunology.

[11]  Gregory M. Frank,et al.  STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV-1 Infection, and Inhibits IL-10+ Regulatory CD8+ T Cells in Autoimmune Uveitis , 2013, Mediators of inflammation.

[12]  O. Leo,et al.  Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes , 2013, Proceedings of the National Academy of Sciences.

[13]  P. Menheere,et al.  Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators , 2013, Journal of Neuroimmunology.

[14]  E. Celis,et al.  Adoptive Transfer of Tc1 or Tc17 Cells Elicits Antitumor Immunity against Established Melanoma through Distinct Mechanisms , 2013, The Journal of Immunology.

[15]  S. Pedreiro,et al.  Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis , 2013, Rheumatology International.

[16]  T. Mak,et al.  IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. , 2013, The Journal of clinical investigation.

[17]  S. Negrini,et al.  Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. , 2012, Autoimmunity reviews.

[18]  K. Pang,et al.  CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. , 2012, Gastroenterology.

[19]  R. Liblau,et al.  Tc17 CD8+ T Cells Potentiate Th1-Mediated Autoimmune Diabetes in a Mouse Model , 2012, The Journal of Immunology.

[20]  D. Wakita,et al.  The development of IL‐17/IFN‐γ‐double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter , 2012, European journal of immunology.

[21]  O. Lee,et al.  Cytokine Profiles in Various Graft-Versus-Host Disease Target Organs following Hematopoietic Stem Cell Transplantation , 2012, Cell transplantation.

[22]  C. Liao,et al.  CD4+ T Cells Disarm or Delete Cytotoxic T Lymphocytes under IL-17–Polarizing Conditions , 2012, The Journal of Immunology.

[23]  M. Wüthrich,et al.  Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4+ T Cells , 2012, PLoS pathogens.

[24]  H. Sai,et al.  Conserved Intergenic Elements and DNA Methylation Cooperate to Regulate Transcription at the il17 Locus* , 2012, The Journal of Biological Chemistry.

[25]  J. Sprent,et al.  The role of interleukin-2 during homeostasis and activation of the immune system , 2012, Nature Reviews Immunology.

[26]  N. Chaput,et al.  Human CD90 Identifies Th17/Tc17 T Cell Subsets That Are Depleted in HIV-Infected Patients , 2012, The Journal of Immunology.

[27]  D. Bhattacharya,et al.  Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4+ and CD8+ T Cells , 2011, The Journal of Biological Chemistry.

[28]  D. Wakita,et al.  IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. , 2011, International immunology.

[29]  N. Shan,et al.  Increased Number of Tc17 and Correlation with Th17 Cells in Patients with Immune Thrombocytopenia , 2011, PloS one.

[30]  J. Kolls,et al.  Mechanisms controlling Th17 cytokine expression and host defense , 2011, Journal of leukocyte biology.

[31]  C. Abraham,et al.  Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses , 2011, Proceedings of the National Academy of Sciences.

[32]  Xiao-jun Huang,et al.  IL‐17‐producing T cells contribute to acute graft‐versus‐host disease in patients undergoing unmanipulated blood and marrow transplantation , 2011, European journal of immunology.

[33]  R. Mechelli,et al.  CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. , 2011, Brain : a journal of neurology.

[34]  P. Teeling,et al.  Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis , 2010, PloS one.

[35]  P. Morel,et al.  T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses , 2010, The Journal of Immunology.

[36]  M. Kaplan,et al.  Tc17 Cells Are Capable of Mediating Immunity to Vaccinia Virus by Acquisition of a Cytotoxic Phenotype , 2010, The Journal of Immunology.

[37]  L. Cosmi,et al.  CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC , 2010, European journal of immunology.

[38]  D. Kuang,et al.  Tumor-Activated Monocytes Promote Expansion of IL-17–Producing CD8+ T Cells in Hepatocellular Carcinoma Patients , 2010, The Journal of Immunology.

[39]  T. Yoshimoto,et al.  A Pivotal Role for Interleukin-27 in CD8+ T Cell Functions and Generation of Cytotoxic T Lymphocytes , 2010, Journal of biomedicine & biotechnology.

[40]  R. Dutton,et al.  Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice , 2010, The Journal of Immunology.

[41]  J. Flint,et al.  Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties , 2010, Proceedings of the National Academy of Sciences.

[42]  S. Pedreiro,et al.  Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. , 2010, Cellular immunology.

[43]  D. Getnet,et al.  Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity1 , 2009, The Journal of Immunology.

[44]  M. Huber,et al.  A Th17‐like developmental process leads to CD8+ Tc17 cells with reduced cytotoxic activity , 2009, European journal of immunology.

[45]  S. Way,et al.  IL-23 Promotes the Production of IL-17 by Antigen-Specific CD8 T Cells in the Absence of IL-12 and Type-I Interferons1 , 2009, The Journal of Immunology.

[46]  Mohamed El-behi,et al.  IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells1 , 2009, The Journal of Immunology.

[47]  T. Strutt,et al.  Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge1 , 2009, The Journal of Immunology.

[48]  M. Takiguchi,et al.  Cutting Edge: Phenotypic Characterization and Differentiation of Human CD8+ T Cells Producing IL-171 , 2009, The Journal of Immunology.

[49]  James T. Elder,et al.  Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 , 2008, The Journal of Immunology.

[50]  B. Burrell,et al.  CD8+ Th17 Mediate Costimulation Blockade-Resistant Allograft Rejection in T-bet-Deficient Mice1 , 2008, The Journal of Immunology.

[51]  H. Mollenkopf,et al.  Restricted expression of C‐type lectin‐like natural killer receptors by CD8 T cells in the murine small intestine , 2008, Immunology.

[52]  E. Wherry,et al.  Anomalous Type 17 Response to Viral Infection by CD8+ T Cells Lacking T-bet and Eomesodermin , 2008, Science.

[53]  Y. Iwakura,et al.  IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells , 2008, The Journal of experimental medicine.

[54]  B. Walker,et al.  CD161 expression on hepatitis C virus–specific CD8+ T cells suggests a distinct pathway of T cell differentiation , 2008, Hepatology.

[55]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.

[56]  Y. Sher,et al.  Induction of a distinct CD8 Tnc17 subset by transforming growth factor‐β and interleukin‐6 , 2007, Journal of leukocyte biology.

[57]  A. Cabral,et al.  Autoimmune inflammation from the Th17 perspective. , 2007, Autoimmunity reviews.

[58]  C. Elmets,et al.  CD8+ IL-17-Producing T Cells Are Important in Effector Functions for the Elicitation of Contact Hypersensitivity Responses1 , 2006, The Journal of Immunology.

[59]  L. Hennighausen,et al.  Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.

[60]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[61]  S. Strober,et al.  Expression of CD161 (NKR-P1A) Defines Subsets of Human CD4 and CD8 T Cells with Different Functional Activities1 , 2006, The Journal of Immunology.

[62]  David M. Conrad,et al.  Antibody blockade of Thy‐1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti‐CD3 monoclonal antibody , 2005, Immunology and cell biology.

[63]  J. Shellito,et al.  Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection1 , 2003, The Journal of Immunology.

[64]  L. Lanier,et al.  Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. , 1994, Journal of immunology.

[65]  F. Annunziato,et al.  Role of TH1/TH2 Cytokines in HIV Infection , 1994, Immunological reviews.

[66]  H. Young,et al.  IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. , 1990, Journal of immunology.